The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from Marketwire

ProMetic to Present at BioFinance 2010

Tuesday, April 06, 2010

ProMetic to Present at BioFinance 201012:51 EDT Tuesday, April 06, 2010MONTREAL, QUEBEC--(Marketwire - April 6, 2010) - ProMetic Life Sciences Inc. (TSX:PLI) ("ProMetic") today announced that Mr. Pierre Laurin, President and Chief Executive Officer, will present at BioFinance 2010. ProMetic's presentation is scheduled for 10:30 (EDT) on Wednesday, April 7, 2010, in the Trinity III Room of the Toronto Marriott Eaton Centre. Details regarding the conference can be obtained at BioFinance2010 BioFinance 2010 ( is the leading investor conference in Canada for the life sciences industry. This event brings together key industry players interested in investment opportunities and issues affecting companies in the life sciences sector. About ProMetic Life Sciences Inc. ProMetic Life Sciences Inc. ("ProMetic") ( is a biopharmaceutical company specialized in the research, development, manufacture and marketing of a variety of commercial applications derived from its proprietary Mimetic Ligand(TM) technology. This technology is used in large-scale purification of biologics and the elimination of pathogens. ProMetic is also active in therapeutic drug development with the mission to bring to market effective, innovative, lower cost, less toxic products for the treatment of hematology and cancer. Its drug discovery platform is focused on replacing complex, expensive proteins with synthetic "drug-like" protein mimetics. Headquartered in Montreal (Canada), ProMetic has R&D facilities in the UK, the U.S. and Canada, manufacturing facilities in the UK and business development activities in the U.S., Europe, Asia and in the Middle-East.FOR FURTHER INFORMATION PLEASE CONTACT: ProMetic Life Sciences Inc. Pierre Laurin President and CEO 514-341-2115 or ProMetic Life Sciences Inc. Anne Leduc Manager, Investor Relations & Communications 514-341-2115